logo
  • About us
    • The Company in brief
    • Strategy
    • Market
    • Organisation
      • Management
      • Board of Directors
  • Our Drug Projects
    • Science
    • Pipeline
    • Disorders
      • Primary Biliary Cholangitis (PBC)
      • Hepatic Encephalopathy (HE)
  • Investors
    • Financial Reports and Presentations
    • Corporate Governance
    • General meetings
    • Calendar
    • Press Releases
  • Media
    • Press Releases
    • Subscribe
  • Contact

Annual General Meeting 2022

June 17, 2022

The annual general meeting of 2022 was held on Friday 17 June 2022.

Documents

  • Kallelse Till Årsstämma 2022
    May 18, 2022 Swedish
  • Notice To Attend AGM 2022
    May 18, 2022 English
  • Fullmaktsformulär
    May 18, 2022 Swedish
  • Power of attorney form
    May 18, 2022 English
  • Investors
    • Financial Reports and Presentations
    • Corporate Governance
    • General meetings
    • Calendar
    • Press Releases

CONTACT

Viktor Drvota
CEO and Chairman of the Board
Phone +46 8-524 860 70
[email protected]

All contacts

VISITING ADDRESS

Umecrine Cognition AB
Karolinska Institutet Science Park
Nanna Svartz väg 6A,
171 65 Solna
Sweden

COMPANY INFORMATION

Umecrine Cognition AB
Registered office in Umeå
Reg no 556698-3655

  • Cookies
  • Privacy Policy